These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33588438)

  • 1. Antibacterial Resistance Leadership Group 2.0: Back to Business.
    Chambers HF; Evans SR; Patel R; Cross HR; Harris AD; Doi Y; Boucher HW; van Duin D; Tsalik EL; Holland TL; Pettigrew MM; Tamma PD; Hodges KR; Souli M; Fowler VG
    Clin Infect Dis; 2021 Aug; 73(4):730-739. PubMed ID: 33588438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial resistance leadership group: open for business.
    Chambers HF; Bartlett JG; Bonomo RA; Chiou C; Cosgrove SE; Cross HR; Daum RS; Downing M; Evans SR; Knisely J; Kreiswirth BN; Lautenbach E; Mickley BS; Patel R; Pettigrew MM; Rodvold KA; Spellberg B; Fowler VG
    Clin Infect Dis; 2014 Jun; 58(11):1571-6. PubMed ID: 24610430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Manca C; Hill C; Hujer AM; Patel R; Evans SR; Bonomo RA; Kreiswirth BN;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S13-S17. PubMed ID: 28350898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doernberg SB; Lodise TP; Thaden JT; Munita JM; Cosgrove SE; Arias CA; Boucher HW; Corey GR; Lowy FD; Murray B; Miller LG; Holland TL;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S24-S29. PubMed ID: 28350900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doi Y; Bonomo RA; Hooper DC; Kaye KS; Johnson JR; Clancy CJ; Thaden JT; Stryjewski ME; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S30-S35. PubMed ID: 28350901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Chambers HF; Cross HR; Evans SR; Kreiswirth BN; Fowler VG;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S3-S7. PubMed ID: 28350896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Anderson DJ; Jenkins TC; Evans SR; Harris AD; Weinstein RA; Tamma PD; Han JH; Banerjee R; Patel R; Zaoutis T; Lautenbach E;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S36-S40. PubMed ID: 28350902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
    Cross HR; Harris A; Arias RM; Chambers HF; Fowler VG; ;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S8-S12. PubMed ID: 28350897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
    Huvane J; Komarow L; Hill C; Tran TT; Pereira C; Rosenkranz SL; Finnemeyer M; Earley M; Jiang HJ; Wang R; Lok J; Evans SR;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S18-S23. PubMed ID: 28350899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
    Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
    J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Benjamin DK; Bradley J; Guidos RJ; Jones RN; Murray BE; Bonomo RA; Gilbert D;
    Clin Infect Dis; 2013 Jun; 56(12):1685-94. PubMed ID: 23599308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogens resistant to antibacterial agents.
    Chen LF; Chopra T; Kaye KS
    Infect Dis Clin North Am; 2009 Dec; 23(4):817-45, vii. PubMed ID: 19909886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of Global Antibiotic Resistance.
    Morehead MS; Scarbrough C
    Prim Care; 2018 Sep; 45(3):467-484. PubMed ID: 30115335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It.
    Breijyeh Z; Jubeh B; Karaman R
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32187986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
    Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
    Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches.
    Karaman R; Jubeh B; Breijyeh Z
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32586045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 20. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
    Gupta V; Datta P
    Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.